Company intelligence / Profile preview

Tallgrass

Ownership: Private
Development stage: Commercial

Overview

Invests in early-stage agriculture and food tech startups; portfolio includes gene editing platforms for crops but not human health or therapeutics. No clinical programs. Not involved in drug development. Portfolio includes ag-biotech but not human health biotech. Example portfolio companies work on plant genetics, crop intelligence, pheromone-based pest control—none are healthcare-focused. Recent investments include GeneNeer Ltd., which develops gene editing tools for crops—not humans. No clinical results relevant to human medicine.

Industry: Investors

Beyond the preview

Go deeper on Tallgrass.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tallgrass.

Explore the full profile